123 related articles for article (PubMed ID: 35723067)
1. AuNCs-LHRHa nano-system for FL/CT dual-mode imaging and photothermal therapy of targeted prostate cancer.
Wang Z; He L; Che S; Xing H; Guan L; Yang Z; Li X; Zvyagin AV; Lin Q; Qu W
J Mater Chem B; 2022 Jul; 10(27):5182-5190. PubMed ID: 35723067
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional nano-system for multi-mode targeted imaging and enhanced photothermal therapy of metastatic prostate cancer.
Wang Z; Xing H; Liu A; Guan L; Li X; He L; Sun Y; Zvyagin AV; Yang B; Lin Q
Acta Biomater; 2023 Aug; 166():581-592. PubMed ID: 37172637
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional Nanotheranostic Gold Nanocage/Selenium Core-Shell for PAI-Guided Chemo-Photothermal Synergistic Therapy in vivo.
Fang X; Lui KH; Li S; Lo WS; Li X; Gu Y; Wong WT
Int J Nanomedicine; 2020; 15():10271-10284. PubMed ID: 33364758
[TBL] [Abstract][Full Text] [Related]
4. Novel nanoparticle AuNCs conjugated with Desmoglein-3 antibody for FL/CT dual-mode targeted imaging and precise treatment of lung squamous cell carcinoma.
Zhang Y; Yang Z; Song L; Li Y; Lin Q
J Colloid Interface Sci; 2024 Apr; 659():1003-1014. PubMed ID: 38224630
[TBL] [Abstract][Full Text] [Related]
5. [The role of a 6-month depot form of hormone therapy in the treatment of advanced hormone-dependent prostate cancer: Results from the 'ELIRE' observational study].
Ouzaid I; Rouprêt M
Prog Urol; 2011 Nov; 21(12):866-74. PubMed ID: 22035913
[TBL] [Abstract][Full Text] [Related]
6. "All in one" nanoprobe Au-TTF-1 for target FL/CT bioimaging, machine learning technology and imaging-guided photothermal therapy against lung adenocarcinoma.
Yang Z; Zhang Y; Tang L; Yang X; Song L; Shen C; Zvyagin AV; Li Y; Yang B; Lin Q
J Nanobiotechnology; 2024 Jan; 22(1):22. PubMed ID: 38184620
[TBL] [Abstract][Full Text] [Related]
7. Single-chain antibody-decorated Au nanocages@liposomal layer nanoprobes for targeted SERS imaging and remote-controlled photothermal therapy of melanoma cancer cells.
Farahavar G; Abolmaali SS; Nejatollahi F; Safaie A; Javanmardi S; Khajeh Zadeh H; Yousefi R; Nadgaran H; Mohammadi-Samani S; Tamaddon AM; Ahadian S
Mater Sci Eng C Mater Biol Appl; 2021 May; 124():112086. PubMed ID: 33947576
[TBL] [Abstract][Full Text] [Related]
8. Cell Membrane-Inspired Polymeric Vesicles for Combined Photothermal and Photodynamic Prostate Cancer Therapy.
Hu J; Luo H; Qu Q; Liao X; Huang C; Chen J; Cai Z; Bao Y; Chen G; Li B; Cui W
ACS Appl Mater Interfaces; 2020 Sep; 12(38):42511-42520. PubMed ID: 32897691
[TBL] [Abstract][Full Text] [Related]
9. Folic acid-conjugated silica capped gold nanoclusters for targeted fluorescence/X-ray computed tomography imaging.
Zhou Z; Zhang C; Qian Q; Ma J; Huang P; Zhang X; Pan L; Gao G; Fu H; Fu S; Song H; Zhi X; Ni J; Cui D
J Nanobiotechnology; 2013 May; 11():17. PubMed ID: 23718865
[TBL] [Abstract][Full Text] [Related]
10. A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal Oestradiol.
Langley RE; Kynaston HG; Alhasso AA; Duong T; Paez EM; Jovic G; Scrase CD; Robertson A; Cafferty F; Welland A; Carpenter R; Honeyfield L; Abel RL; Stone M; Parmar MK; Abel PD
Eur Urol; 2016 Jun; 69(6):1016-25. PubMed ID: 26707868
[TBL] [Abstract][Full Text] [Related]
11. The role of polyethylenimine-functionalized gold nanoclusters carrying plasmid CMTM5 in impeding the malignant progression of prostate cancer cells by promoting EGFR endocytosis.
Li L; Li C; Miao F; Chen W; Kong X; Ye R; Feng R
Neoplasma; 2024 Feb; 71(1):48-59. PubMed ID: 38295104
[TBL] [Abstract][Full Text] [Related]
12. Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer.
Gilbert DC; Duong T; Kynaston HG; Alhasso AA; Cafferty FH; Rosen SD; Kanaga-Sundaram S; Dixit S; Laniado M; Madaan S; Collins G; Pope A; Welland A; Nankivell M; Wassersug R; Parmar MK; Langley RE; Abel PD
BJU Int; 2017 May; 119(5):667-675. PubMed ID: 27753182
[TBL] [Abstract][Full Text] [Related]
13. Theranostic Nanocages for Imaging and Photothermal Therapy of Prostate Cancer Cells by Active Targeting of Neuropeptide-Y Receptor.
Avvakumova S; Galbiati E; Sironi L; Locarno SA; Gambini L; Macchi C; Pandolfi L; Ruscica M; Magni P; Collini M; Colombo M; Corsi F; Chirico G; Romeo S; Prosperi D
Bioconjug Chem; 2016 Dec; 27(12):2911-2922. PubMed ID: 27809498
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09).
Langley RE; Cafferty FH; Alhasso AA; Rosen SD; Sundaram SK; Freeman SC; Pollock P; Jinks RC; Godsland IF; Kockelbergh R; Clarke NW; Kynaston HG; Parmar MK; Abel PD
Lancet Oncol; 2013 Apr; 14(4):306-16. PubMed ID: 23465742
[TBL] [Abstract][Full Text] [Related]
15. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone.
Efstathiou E; Davis JW; Pisters L; Li W; Wen S; McMullin RP; Gormley M; Ricci D; Titus M; Hoang A; Zurita AJ; Tran N; Peng W; Kheoh T; Molina A; Troncoso P; Logothetis CJ
Eur Urol; 2019 Oct; 76(4):418-424. PubMed ID: 31176622
[TBL] [Abstract][Full Text] [Related]
17. Prostate Cancer Targeted X-Ray Fluorescence Imaging via Gold Nanoparticles Functionalized With Prostate-Specific Membrane Antigen (PSMA).
Hara D; Tao W; Totiger TM; Pourmand A; Dogan N; Ford JC; Shi J; Pollack A
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):220-232. PubMed ID: 33964351
[TBL] [Abstract][Full Text] [Related]
18. Pea Protein/Gold Nanocluster/Indocyanine Green Ternary Hybrid for Near-Infrared Fluorescence/Computed Tomography Dual-Modal Imaging and Synergistic Photodynamic/Photothermal Therapy.
Wu M; Li Z; Yao J; Shao Z; Chen X
ACS Biomater Sci Eng; 2019 Sep; 5(9):4799-4807. PubMed ID: 33448822
[TBL] [Abstract][Full Text] [Related]
19. Microwave-triggered/HSP-targeted gold nano-system for triple-negative breast cancer photothermal therapy.
Cheng Y; Bao D; Chen X; Wu Y; Wei Y; Wu Z; Li F; Piao JG
Int J Pharm; 2021 Jan; 593():120162. PubMed ID: 33307159
[TBL] [Abstract][Full Text] [Related]
20. Gold nanoclusters modified mesoporous silica coated gold nanorods: Enhanced photothermal properties and fluorescence imaging.
Duan Q; Yang M; Zhang B; Li Y; Zhang Y; Li X; Wang J; Zhang W; Sang S
J Photochem Photobiol B; 2021 Feb; 215():112111. PubMed ID: 33373860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
